#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13274	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2079	633.8	0	.	n	.	0	C1450T	SNP	1450	1450	C	1684	1684	T	751	T,C	681,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13274	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2079	633.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1418	1418	C	764	C	704	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13274	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2079	633.8	0	HET	.	.	.	A69G	.	69	69	A	303	303	A	740	A,G	392,299	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24592	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3478	704.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1641	1641	A	808	A,G	745,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24592	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3478	704.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2275	2275	C	799	C	733	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24592	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3478	704.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2349	2349	A	778	A	724	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24592	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3478	704.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2901	2901	C	769	C	719	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_W_01420c	folP.WHO_W_01420c	1	1	539	1936	folP	852	852	99.88	folP.l15.c17.ctg.1	1489	129.2	0	.	p	.	0	E151K	NONSYN	451	453	GAA	764	766	AAA	178;179;178	A,G;A;A	171,2;171;173	.	.
folP.WHO_W_01420c	folP.WHO_W_01420c	1	1	539	1936	folP	852	852	99.88	folP.l15.c17.ctg.1	1489	129.2	1	SNP	p	R228S	1	.	.	682	684	AGC	995	997	AGC	192;190;192	A;G;C	181;179;181	folP.WHO_W_01420c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5044	gyrA	2751	2751	100.0	gyrA.l15.c17.ctg.1	3489	144.2	1	SNP	p	S91F	0	.	.	271	273	TCC	700	702	TCC	174;174;172	T;C,T;C	160;158,1;161	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5044	gyrA	2751	2751	100.0	gyrA.l15.c17.ctg.1	3489	144.2	1	SNP	p	D95N	0	.	.	283	285	GAC	712	714	GAC	172;171;170	G;A,G;C	156;156,1;156	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5044	gyrA	2751	2751	100.0	gyrA.l15.c17.ctg.1	3489	144.2	1	SNP	p	D95G	0	.	.	283	285	GAC	712	714	GAC	172;171;170	G;A,G;C	156;156,1;156	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1536	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1285	119.0	1	SNP	p	G45D	0	.	.	133	135	GGC	475	477	GGC	188;186;191	G;G;C	172;167;172	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	816	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	897	90.1	0	.	n	.	0	A197.	DEL	197	197	A	519	519	A	191	A	181	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4810	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3101	154.7	1	SNP	p	D86N	0	.	.	256	258	GAC	619	621	GAC	210;208;207	G;A;C	191;189;190	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4810	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3101	154.7	1	SNP	p	S87R	0	.	.	259	261	AGT	622	624	AGT	205;201;202	A;G;T	187;185;187	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4810	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3101	154.7	1	SNP	p	S87W	0	.	.	259	261	AGT	622	624	AGT	205;201;202	A;G;T	187;185;187	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4810	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3101	154.7	1	SNP	p	S87I	0	.	.	259	261	AGT	622	624	AGT	205;201;202	A;G;T	187;185;187	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4810	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3101	154.7	1	SNP	p	S88P	0	.	.	262	264	TCC	625	627	TCC	202;205;204	T;C;C	186;188;182	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4064	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2649	152.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1458	1460	GGC	206;203;202	G,A;G;C	194,1;189;186	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	3694	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2449	150.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1323	1325	GCA	224;224;221	G;C,A;A,C	198;194,1;196,1	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3694	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2449	150.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1326	1328	ATC	220;221;222	A;T;C,A	200;200;200,1	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3694	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2449	150.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1338	1340	GTG	222;224;224	G;T;G	198;197;200	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3694	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2449	150.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1338	1340	GTG	222;224;224	G;T;G	198;197;200	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3694	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2449	150.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1842	1844	ACC	210;210;209	A;C;C	193;191;193	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3694	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2449	150.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1896	1898	GCG	192;192;190	G;C;G	170;160;162	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3694	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2449	150.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1896	1898	GCG	192;192;190	G;C;G	170;160;162	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3694	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2449	150.4	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2019	2021	GGC	158;153;152	G;G;C	143;135;138	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3694	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2449	150.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2028	2030	GGC	152;151;146	G;G;C	141;138;136	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3694	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2449	150.4	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2046	2048	CTG	148;149;151	C,G,A;T;G	119,3,1;118;127	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5418	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3095	174.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1638	1640	CCG	194;197;199	C;C,T;G,A	170;178,1;170,2	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2210	porA	1146	1146	99.65	porA.l6.c4.ctg.1	1744	126.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	502	502	C	163	C,A	145,1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	298	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	435	24.4	0	.	p	.	0	V258L	NONSYN	772	774	GTA	106	108	TTA	47;50;50	T;T;A	41;43;44	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	298	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	435	24.4	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	151	153	CAT	48;47;47	C;A;T	46;44;45	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	298	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	435	24.4	0	.	p	.	0	D274S	NONSYN	820	822	GAT	154	156	AGT	47;47;47	A;G;T	45;45;45	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	298	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	435	24.4	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	163	165	TAC	47;47;47	T;A;C	45;45;45	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	298	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	435	24.4	0	.	p	.	0	R307A	NONSYN	919	921	AGA	253	255	GCA	13;13;13	G;C;A	13;13;13	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	298	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	435	24.4	0	.	p	.	0	T311A	NONSYN	931	933	ACA	265	267	GCA	15;15;15	G;C;A	15;15;15	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	298	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	435	24.4	0	.	p	.	0	E312D	NONSYN	934	936	GAA	268	270	GAC	15;14;14	G;A;C	15;14;14	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	298	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	435	24.4	0	.	p	.	0	F314I	NONSYN	940	942	TTC	274	276	ATC	15;15;15	A;T;C	14;14;14	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	298	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	435	24.4	0	.	p	.	0	A316S	NONSYN	946	948	GCG	280	282	TCG	15;15;15	T;C;G	14;15;14	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	298	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	435	24.4	0	.	p	.	0	V318A	NONSYN	952	954	GTC	286	288	GCC	15;15;15	G;C;C	14;14;14	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	298	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	435	24.4	0	.	p	.	0	G319S	NONSYN	955	957	GGC	289	291	AGC	15;15;15	A;G;C	14;14;14	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	298	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	435	24.4	0	.	p	.	0	G320A	NONSYN	958	960	GGT	292	294	GCC	15;15;15	G;C;C	14;13;13	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	298	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	435	24.4	0	.	p	.	0	G322V	NONSYN	964	966	GGT	298	300	GTT	15;15;15	G;T;T	14;15;14	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2454	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1481	164.8	0	.	p	.	0	N38E	NONSYN	112	114	AAT	405	407	GAA	213;213;212	G;A;A	195;194;193	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2454	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1481	164.8	0	.	p	.	0	N134D	NONSYN	400	402	AAT	693	695	GAT	199;199;200	G;A;T	185;184;185	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2454	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1481	164.8	0	.	p	.	0	P175S	NONSYN	523	525	CCA	816	818	TCA	220;221;219	T;C;A	201;202;203	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2454	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1481	164.8	0	.	p	.	0	A218V	NONSYN	652	654	GCC	945	947	GTC	216;217;215	G;T;C	201;202;200	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2454	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1481	164.8	0	.	p	.	0	F222S	NONSYN	664	666	TTT	957	959	TCT	209;208;206	T;C;T	191;190;189	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2454	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1481	164.8	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1275	1277	GCA	199;198;199	G;C;A	179;179;178	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2454	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1481	164.8	1	SNP	p	G120K	1	.	.	358	360	AAG	651	653	AAG	198;195;198	A;A;G	187;185;185	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2454	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1481	164.8	1	SNP	p	A121D	1	.	.	361	363	GAC	654	656	GAC	198;197;197	G;A;C	187;187;187	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2454	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1481	164.8	1	SNP	p	D121N	0	.	.	361	363	GAC	654	656	GAC	198;197;197	G;A;C	187;187;187	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	308	porB3	990	116	92.24	porB3.l15.c17.ctg.2	290	43.8	0	.	p	.	0	M18T	NONSYN	52	54	ATG	180	182	ACG	67;67;64	A;C;G	64;64;62	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	308	porB3	990	116	92.24	porB3.l15.c17.ctg.2	290	43.8	0	.	p	.	0	T29A	NONSYN	85	87	ACC	213	215	GCC	61;58;55	G;C;C	57;56;53	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	308	porB3	990	116	92.24	porB3.l15.c17.ctg.2	290	43.8	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	222	224	CAA	38;34;29	C;A;A	35;31;28	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	308	porB3	990	116	92.24	porB3.l15.c17.ctg.2	290	43.8	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	228	230	TAC	24;20;16	T;A;C	22;17;15	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	9644	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4762	201.9	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	1962	1964	AAT	219;217;217	A;A;T	205;202;201	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	980	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1147	85.3	1	SNP	p	V57M	1	.	.	169	171	ATG	540	542	ATG	203;200;204	A;T;G	190;188;188	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
